Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 19, 2026 13:36 ET | Source: Asthma and Allergy Foundation of America

AAFA Calls on Federal Health Officials to Take Action on Food Allergies

Washington, DC, March 19, 2026 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA), as well as leading allergy medical societies the American Academy of Allergy,...
March 10, 2026 07:30 ET | Source: Piston Bio

Piston Bio Announces FDA Alignment on PST-101 Development Program for Cancer-Related Apathy

MORRISTOWN, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Piston Bio LLC, a clinical-stage biotechnology company developing therapeutics targeting neuroimmune mechanisms in cancer, today announced the...
January 28, 2026 17:04 ET | Source: Elevar Therapeutics

Elevar Therapeutics Submits New Drug Application to FDA for Lirafugratinib as Second-Line Treatment Option for Cholangiocarcinoma

FORT LEE, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
September 16, 2025 08:00 ET | Source: Regen BioPharma, Inc.

Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate

SAN DIEGO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company is in the process of addressing comments received by the U.S....
July 10, 2025 08:00 ET | Source: 22nd Century Group, Inc.

22nd Century Provides Corporate Update On Its VLN® MRTP Renewal Process – The First and Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less

Extensive Clinical Data Continues to Demonstrate VLN® Reduced Nicotine Content Tobacco Helps Reduce Smoking and Increase Quit Attempts Growing List of VLN® Based Cigarette Brands Bring Non-Addictive...
June 18, 2025 08:00 ET | Source: PharmaTher Holdings Ltd.

PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders, and National Security Applications

TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) ("PharmaTher" or the "Company"), a company focused on unlocking the pharmaceutical potential of...
October 23, 2024 08:00 ET | Source: PharmaTher Holdings Ltd.

PharmaTher Receives Complete Response Letter from the U.S. Food and Drug Administration for Ketamine Abbreviated New Drug Application

TORONTO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the U.S. Food...
May 07, 2024 10:00 ET | Source: Dipharma Francis S.r.l

Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA

Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process.
March 23, 2024 10:15 ET | Source: UsAgainstAlzheimer's

Congress Passes Bills Making Major Investments in Alzheimer’s

Congress passes major investments in the fight against Alzheimer’s.
March 14, 2024 17:50 ET | Source: The Rosen Law Firm PA

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages InMode Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INMD

NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of InMode Ltd. (NASDAQ: INMD) between June 4, 2021 and...